Monika Stoll
Monika Stoll is an expert in Cardiology at University Hospital Münster (Germany). Monika Stoll has authored 241 publications, the most recent in 2026, and is an investigator in 2 clinical trials. SLR score: 657 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Genetics - Biochemistry - Immunology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2003 - 2026
Number : 241
Citations
Main journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Transcriptomic Analysis Suggests Overlapping Molecular Pathogenesis in JIA-Associated and ANA-Positive Uveitis. PMID 42072655 — genes, gene expression profiling, uveitis, anterior, transcriptome, glaucoma, arthritis, juvenile, tissues, iris, uveitis | Biomolecules | 2026 | 0 |
| Immune cell profiling reveals expanded stem cell-like memory T cells in anti-GAD65-associated neurological syndromes. PMID 41880578 — cells, genes, microscopy, electron, scanning transmission, stem cells, memory | Proc Natl Acad Sci U S A | 2026 | 0 |
| Long-term immune recovery under continuous antiretroviral therapy (ART) among ART-naive people living with HIV in two cohorts in Germany. PMID 41748859 — cd4 lymphocyte count, cells, probability, recycling, cd4-cd8 ratio, hiv, cell count, therapeutics, art therapy, infections | Infection | 2026 | 0 |
| Higher sensitivity to ouabain-induced toxicity in human induced pluripotent stem cell-derived cardiomyocytes than human adult heart tissue despite similar Na +/K +-ATPase pump current amplitudes. PMID 41731308 — cells, electrophysiology, microscopy, electron, scanning transmission, pluripotent stem cells, heart, action potentials, stem cells, drug therapy, pharmacology, induced pluripotent stem cells, tissues, ouabain, myocytes, cardiac | Br J Pharmacol | 2026 | 0 |
| Rivaroxaban treatment prevents atrial myocyte hypertrophy in goats with persistent atrial fibrillation by inhibition of protease-activated receptor-1. PMID 41506646 — genes, muscle cells, thrombin, rivaroxaban, receptors, proteinase-activated, hypertrophy, atrial fibrillation, receptor, par-1, peptide hydrolases, therapeutics, thrombosis, hemodynamics, hemostasis, gene expression | Thromb Haemost | 2026 | 0 |
Clinical Studies 2
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 9
LeadR Networks
Main global connection map